RS1 and cyst: Initially, a subretinal injection of a 2 × 109 vg/mL dose of AAV2/4-EF1α-RS1 in Rs1-KO mice did improve functional metrics such as cyst severity and cone electrical functioning, when compared to untreated Rs1-KO controls.